OKYO Pharma (FRA:OK10) Buyback Yield %: -5.79 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OK10 OKYO Pharma Ltd FRA:OK10
23 GF Score
Price €1.36
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Buyback Yield %?

OKYO Pharma FRA:OK10 23 Buyback Yield % is -5.79 as of Jul. 19, 2026. GuruFocus rates FRA:OK10 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 740 Biotechnology companies, OKYO Pharma ranks better than 57.7% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

OKYO Pharma's current buyback yield was -5.79%.

OKYO Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Buyback Yield % Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -10.15 -12.60 -3.22

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.41 -12.50 -6.38 -3.73 -5.61

FRA:OK10 vs ENTX, HRTX, RANI: Buyback Yield % Comparison

For the Biotechnology subindustry, OKYO Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OKYO Pharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Buyback Yield % falls into.


FRA:OK10
23GF Score
OKYO Pharma Ltd FRA:OK10
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

OKYO Pharma's Buyback Yield for the fiscal year that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.578) / 48.98856
=-3.22%

OKYO Pharma's annualized Buyback Yield for the quarter that ended in Sep. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3.678) / 52.2988
=-7.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -5.79 mean?
OKYO Pharma (FRA:OK10) has a Buyback Yield % of -5.79 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #313 out of 740 companies in the Biotechnology industry, placing it in the top 42.3%.
Is OKYO Pharma's Buyback Yield % too high?
OKYO Pharma's current Buyback Yield % is -5.79. Based on the distribution chart, OKYO Pharma ranks #313 out of 740 companies in the Biotechnology industry, which is above the industry midpoint. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Buyback Yield % compare to ENTX and HRTX?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #313 out of 740 companies for Buyback Yield %. This puts OKYO Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Buyback Yield % is -5.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (FRA:OK10) has a current Buyback Yield % of -5.79. The current Buyback Yield % is -5.79. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For OKYO Pharma (FRA:OK10), the current Buyback Yield % is -5.79 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Other Exchanges OKYO:USA
Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for FRA:OK10

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.36
Price